3DBio Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • 3DBio's estimated annual revenue is currently $2.6M per year.(i)
  • 3DBio's estimated revenue per employee is $155,000

Employee Data

  • 3DBio has 17 Employees.(i)
  • 3DBio grew their employee count by -51% last year.

3DBio's People

NameTitleEmail/Phone
1
Director, Process Development and Clinical ManufacturingReveal Email/Phone
2
Technical Project Lead, Combination Products R&DReveal Email/Phone
3
Staff EngineerReveal Email/Phone
4
Process EngineerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.6M4-20%N/AN/A
#2
$6.7M438%N/AN/A
#3
$34.4M222-1%N/AN/A
#4
$5.2M670%$10MN/A
#5
$2M130%N/AN/A
#6
$7.5M370%$51.6MN/A
#7
$0.3M2-50%N/AN/A
#8
$4.3M21-16%$3.3MN/A
#9
$3.6M230%N/AN/A
#10
$4.3M56-8%$118MN/A
Add Company

What Is 3DBio?

3DBio Therapeutics is a biologics and bioprinting company with a focus on regenerative medicine that precision manufactures living tissues to allow replacement of each individual patient's parts with tissues designed and created specifically for them. 3DBio has developed unique capabilities toward the creation of living tissue implants for therapeutic applications. The technology platforms include a full suite of features to meet the FDA's requirements for therapeutic manufacturing, including novel and proprietary: 3D-bioprinter (GMPrintâ„¢), bio-ink (ColVivoâ„¢), and cell processes. In pre-clinical studies the platform has demonstrated the ability to generate functioning living tissues.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

-51%

Employee Growth %

N/A

Valuation

N/A

Accelerator

3DBio News

2022-03-22 - 3D Bioprinting Market Is Expected To Grow At A Robust CAGR ...

Report: https://www.futuremarketinsights.com/reports/3d-bio-printing-market · Email this · Facebook · Twitter · LinkedIn · Pinterest...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.8M170%N/A
#2
$1.7M170%N/A
#3
$3.1M18-31%N/A
#4
$1.6M18-5%N/A
#5
N/A19-24%N/A